Close

Tonix Pharma (TNXP) Says TNX-102 SL Phase 3 Did Not Meet Primary Endpoint in Fibromyalgia

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/24/2024

1. TSLA
2. SPY
3. SPOT
4. GM
5. AMZN
6. SHW
7. MSCI
8. NVDA
9. IBM
10. MSFT


Go back to Tonix Pharma (TNXP) Says TNX-102 SL Phase 3 Did Not Meet Primary Endpoint in Fibromyalgia
TONIX PHARM HLDG (NASDAQ: TNXP) Delayed: 0.16 --0 (-0%)
Previous Close $0.16    52 Week High $7.95 
Open $0.16    52 Week Low $0.40 
Day High $0.16    P/E N/A 
Day Low $0.16    EPS $-5.33 
Volume 100